ADIPOQ and cancer: Additionally, adiponectin was significantly lower in patients who used serum as test samples (SMD −0.335, 95% CI, −0.483 to −0.186), and in 37 studies who used plasma as testing samples, 26 studies showed the inverse relation of adiponectin to cancer risk.